BioGaia AB (Sweden) Top Management

BIOG-B Stock  SEK 105.80  0.40  0.38%   
BioGaia AB employs about 212 people. The company is managed by 10 executives with a total tenure of roughly 495 years, averaging almost 49.0 years of service per executive, having 21.2 employees per reported executive. Analysis of BioGaia AB's management performance can provide insight into the company performance.
Gianfranco Grompone  Insider
Chief RD
Eva Nelson  Insider
Co Mang
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioGaia AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

BioGaia AB Management Team Effectiveness

The company has return on total asset (ROA) of 0.1041 % which means that it generated a profit of $0.1041 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1941 %, meaning that it generated $0.1941 on every $100 dollars invested by stockholders. BioGaia AB's management efficiency ratios could be used to measure how well BioGaia AB manages its routine affairs as well as how well it operates its assets and liabilities.

BioGaia AB Workforce Comparison

BioGaia AB is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers - Specialty & Generic industry is currently estimated at about 6,763. BioGaia AB holds roughly 212 in number of employees claiming about 3% of equities under Drug Manufacturers - Specialty & Generic industry.
The company has Profit Margin (PM) of 0.34 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.33 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.33.

BioGaia AB Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. BioGaia AB Price Series Summation is a cross summation of BioGaia AB price series and its benchmark/peer.

BioGaia AB Notable Stakeholders

A BioGaia AB stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BioGaia AB often face trade-offs trying to please all of them. BioGaia AB's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BioGaia AB's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About BioGaia AB Management Performance

The success or failure of an entity such as BioGaia AB often depends on how effective the management is. BioGaia AB management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BioGaia management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BioGaia management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BioGaia AB develops, markets, and sells probiotic products with documented health benefits worldwide. BioGaia AB was founded in 1990 and is headquartered in Stockholm, Sweden. BioGaia AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 144 people.
Please note, the presentation of BioGaia AB's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BioGaia AB's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BioGaia AB's management manipulating its earnings.

BioGaia AB Workforce Analysis

Traditionally, organizations such as BioGaia AB use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BioGaia AB within its industry.

BioGaia AB Manpower Efficiency

Return on BioGaia AB Manpower

Revenue Per Employee5.2M
Revenue Per Executive110.4M
Net Income Per Employee1.8M
Net Income Per Executive37.4M
Working Capital Per Employee1.4M
Working Capital Per Executive28.9M

Complementary Tools for BioGaia Stock analysis

When running BioGaia AB's price analysis, check to measure BioGaia AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioGaia AB is operating at the current time. Most of BioGaia AB's value examination focuses on studying past and present price action to predict the probability of BioGaia AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioGaia AB's price. Additionally, you may evaluate how the addition of BioGaia AB to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets